Fig. 3From: Population-based study of long-term anticoagulation for treatment and secondary prophylaxis of venous thromboembolism in men with prostate cancer in SwedenCumulative incidence (%) of recurrent VTE after the cessation of anticoagulant treatment by duration of therapy and time since cessation of therapy. Note: Analysis included 510 men with VTE and at least 1 year of follow-up after the cessation of therapy. VTE, venous thromboembolismBack to article page